Advance purchase agreement for the reservation and supply of pandemic influenza vaccine
Buyer: Statens Serum Institut
- Published
- 18 November 2024
- Place of performance
- København S, DK011
- Procedure
- Negotiated procedure
- Lots
- 1
- Notice number
- 00699614-2024
- Reference
- 8ed75d6b-04fe-446e-8ba8-0c9dd0bee67c
- Official source
- Official source
CPV codes
- 33651600Vacunas
Description
The purpose of this tender is to ensure fast delivery of pandemic influenza vaccines in the event of an influenza pandemic during the contract period. The contract (advance purchase agreement) regards reservation of the supplier’s production capacity and the contract will contain an option for purchase of pandemic influenza vaccine in the event of an influenza pandemic called by the WHO during the contract period. The reserved volume of pandemic vaccine is expected to be 7.6 million doses; however, the number of doses may be reduced by SSI as described in the tender documents. SSI expects that the Agreement cannot be awarded without prior negotiations with potential suppliers due to the specific circumstances related to the nature and the complexity of the Agreement and the legal and financial aspects and the associated risks. In essence, the procedure encompasses a complex advance purchase agreement, and SSI is dependent on further information from potential suppliers in order to establish a complete and adequate set of terms and conditions in accordance with what the market operators are able to meet. This makes it necessary for SSI to be able to negotiate various as-pects of bo…
Award criteria
- Price — Reference is made to the Tender Specifications, Appendix A, section 1.1.
- Quality — Reference is made to the Tender Specifications, Appendix A, section 1.2.
- Quality — Reference is made to the Tender Specifications, Appendix A, section 1.3.
- Quality — Reference is made to the Tender Specifications, Appendix A, section 1.4.
Awards
| Awarded to | Amount | Date |
|---|---|---|
| Seqirus UK Ltd | — | — |
Official publications
- TED · 00699614-2024 · 18 November 2024
- OJS · 224/2024 · 18 November 2024
Other tenders from Statens Serum Institut
- Respiratory Syncytial Virus Vaccine (RSV vaccine) 2026-2030
- Respiratory Syncytial Virus Vaccine (RSV vaccine) 2026-2030
- Rammeaftale om køb af Abrysvo
- Udbud af rammekontrakter vedr. rabiesvacciner og TBE-vacciner
- Rammeaftale om køb af Abrysvo
- Udbud af rammekontrakter vedr. rabiesvacciner og TBE-vacciner
- Udbud af rammekontrakter vedr. rabiesvacciner og TBE-vacciner (1)
- Udbud af rammekontrakter vedr. rabiesvacciner og TBE-vacciner
- Udbud af rammekontrakter vedr. rabiesvacciner og TBE-vacciner (1)
- Udbud af rammekontrakter vedr. rabiesvacciner og TBE-vacciner
Frequently asked questions
- Who is the buyer of this tender?
- The contracting authority is Statens Serum Institut (European Union).
- How can I bid for public tenders in European Union?
- Bids are submitted through the official procurement portal of European Union. El Vínculo helps you find tenders and analyse their documents; submission always happens at the official source.
Create a free account and receive new tenders from European Union matching your business, every day.